Bionano Genomics (BNGO) Preferred Stock Liabilities (2017)
Bionano Genomics recorded quarterly Preferred Stock Liabilities of $61847.0 in Q4 2017.
Bionano Genomics' Preferred Stock Liabilities history runs 1 years deep, the most recent figure standing at $61847.0 for Q4 2017.
- In Q4 2017, Preferred Stock Liabilities changed N/A year-over-year to $61847.0; the TTM figure through Dec 2017 stood at $61847.0 (changed N/A YoY), while the FY2017 annual figure was $61847.0, changed N/A from the prior year.
- Preferred Stock Liabilities came in at $61847.0 for Q4 2017 at Bionano Genomics.
- In the past five years, Preferred Stock Liabilities ranged from a high of $61847.0 in Q4 2017 to a low of $61847.0 in Q4 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | - |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | - |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | - |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | - |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | - |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | - |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | - |
| 10 | Bionano Genomics | 14.92 Mn | 539,417.67 | 3.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 61,847.00 |